February 19, 1999

8 a.m.-Noon
CME Courses 1-3

9 a.m.-4 p.m.
CME Courses 4-7

10 a.m.-5 p.m.
Registration/Course Enrollment Open

11 a.m.-5 p.m.
APA Resource Center Open
Publishers' Bookfair Open

1 p.m.-5 p.m.
CME Courses 8-12

7 p.m.-10 p.m.
Industry-Supported Symposia
IS1. The Changing Face of Depression
Supported by Forest Laboratories Inc.

1. Diagnosis and Treatment of Childhood Mania Elizabeth B. Weller, M.D.


2. Treatment of Adolescent Depression Richard C. Harrington, M.D.


3. Decision Points in the Treatment of Bipolar Depression Gary S. Sachs, M.D.


4. Therapy for Traumatic Grief M. Katherine Shear, M.D.


5. A Life-Cycle Approach to the Diagnosis and Treatment of Depressive Disorders David J. Kupfer, M.D.

IS2. Redefining Treatment-Resistant Schizophrenia
Supported by Novartis Pharmaceuticals Corporation

1. Natural Course and Outcome of Schizophrenia Thomas H. McGlashan, M.D.


2. Pathogenesis of Treatment and Resistance in Schizophrenia Jeffrey A. Lieberman, M.D.


3. Treatment and Resistance in Schizophrenia Herbert Y. Meltzer, M.D.


4. Early Intervention: Approach to Comorbid Substance Abuse/Substance Use Disorder Alan I. Green, M.D.

IS3. Spectrum of Depression: New Treatment Approaches
Supported by Pharmacia & Upjohn Company Inc.

1. Alternatives to SSRIs in the Treatment of Depression Jack M. Gorman, M.D.


2. Role of Norepinephrine in Depression Pedro L. Delgado, M.D.


3. Treatment of Severe Depression Michael E. Thase, M.D.


4. New Approaches to the Treatment of Refractory Depression Maurizio Fava, M.D.


5. Social Functioning and New Depression Treatments in the Patient With Depression Myrna M. Weissman, Ph.D.